A Review of Advances in Radiotherapy in the Setting of Esophageal Cancers.
Surg Oncol Clin N Am
; 32(3): 433-459, 2023 07.
Article
en En
| MEDLINE
| ID: mdl-37182986
ABSTRACT
Esophageal cancer is the eighth most common cancer worldwide and is the sixth most common cause of cancer-related mortality. The paradigm has shifted to include a multimodality approach with surgery, chemotherapy, targeted therapy (including immunotherapy), and radiation therapy. Advances in radiotherapy through techniques such as intensity modulated radiotherapy and proton beam therapy have allowed for the more dose homogeneity and improved organ sparing. In addition, recent studies of targeted therapies and predictive approaches in patients with locally advanced disease provide clinicians with new approaches to modify multimodality treatment to improve clinical outcomes.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Banco de datos:
MEDLINE
Asunto principal:
Neoplasias Esofágicas
/
Radioterapia de Intensidad Modulada
/
Terapia de Protones
Tipo de estudio:
Prognostic_studies
Límite:
Humans
Idioma:
En
Revista:
Surg Oncol Clin N Am
Asunto de la revista:
NEOPLASIAS
Año:
2023
Tipo del documento:
Article
País de afiliación:
Estados Unidos